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High sodium bicarbonate and acetate hemodialysis: Double-blind cross-
over comparison of hemodynamic and ventilatory effects. The superiority
of bicarbonate dialysis (Bi HD) over acetate dialysis (Ac HD) using a
high sodium dialysate has not been established to our knowledge. We
compared Bi HD to Ac HD over 6 weeks each in ten stable patients
using a double-blind crossover design and a dialysate sodium concen-
tration of 140 mEq/liter. The dialyzer, delivery system, and disalysate
constituents were identical except for the substitution of Bi or Ac.
Interdialytic weight gain, pre- and post-HD blood pressures, and heart
rates were also comparable in the two protocols. Beginning of the week
pre-HD serum Bi was greater during Bi HD than Ac HD (19.1 0.9 vs.
15.1 0.8 mEq/liter, P < 0.001); post-HD Bi values were also higher
during Bi HD. Similarly, pre-HD pH was also greater with Bi HD (7.40
0.012 vs. 7.35 0.001 U, P < 0.01). The number of adverse
symptoms and signs were similar during each protocol (2.0 0.65 for Bi
HD vs. 2.5 0.5 for Ac HD episodes/patient/6 weeks, NS). However,
fewer therapeutic interventions were required during the Bi HD proto-
col (1.5 0.43 vs. 3.1 0.6 treatments/patient/6 weeks, P < 0.02). The
ventilatory effects of the two dialysates were evaluated at the end of the
6-week course in seven of the ten patients and revealed comparable
declines in carbon dioxide excretion, minute ventilation, and arterial
oxygen tension. In summary, these results demonstrate strikingly
similar hemodynamic and ventilatory responses with the two dialysates
when a higher osmolality dialysate is used. However, Bi HD was
associated with a significant reduction in the number of therapeutic
interventions required, and also resulted in a greater pre-HD pH and
bicarbonate concentration.
Hémodialyse avec des concentrations élevées de bicarbonate ou d'acé-
tate de sodium: Une comparaison croisée en double insu des effets
hemodynamiques et ventilatoires. La supériorité de Ia dialyse avec du
bicarbonate (Bi HD) sur Ia dialyse avec de l'acétate (Ac HD) en utilisant
un dialysat riche en sodium n'a pas été établie, a notre connaissance.
Nous avons compare Ia Bi HD a l'Ac HD pendant 6 semaines chacune
avec dix malades stables en utilisant un protocole croisC en double insu,
et une concentration de sodium dans Ic dialysat de 140 mEq/litre. Le
dialyseur, le système d'apport, et les constituants du dialysat étaient
identiques exceptés en ce qui concerne la substitution de Bi ou Ac. La
prise de poids interdialytique, les pressions artérielles pré- et post-HD,
et les rythmes cardiaques étaient egalement comparables dans les deux
protocoles. Au debut de Ia semaine avant HD, Ic Bi sCrique était plus
élevé durant Bi HD que pendant Ac HD (19.1 0.9 contre 15.1 0.8
mEq/litre, P < 0.001); les valeurs de Bi post-HD Ctaient aussi plus
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élevées pendant Bi HD. De Ia méme manière, Ic pH pre-HD était
egalement plus élevé avec Bi HD (7.40 0.012 contre 7.35 0.001 U, P
< 0.01). Le nombre de symptomes ci de signes d'intolérance Ctait
identique pendant chaque protocole (2.0 0.65 pour Bi HD contre 2.5
0.5 pour Ac HD episodes/malade/6 semaines, NS). Cependant moms
d'interventions therapeutiques ont été nécessaires pendant Ic protocole
Bi HD(1.5 0.43 contre 3.1 0.6 traitements/malade/6 semaines, P <
0.02). Les effets ventilatoires des deux dialysats ont été étudiés a Ia fin
de Ia période de 6 semaines chez sept des dix malades et cela a révélé
des diminutions comparables de l'excrétion de dioxyde de carbone, de
la ventilation par minute, et de Ia tension artérielle d'oxygene. En
résumé, ces résultats démontrent des reponses hémodynamiques et
ventilatoires a l'évidence identiques avec les deux dialysats quand une
plus forte osmolalité du dialysat est utilisée. Cependant, Bi HD était
associé avec reduction significative du nombre d'interventions thCra-
peutiques nécessaires, et a egalement été a l'origine d'un bicarbonate ci
d'un pH pré-HD plus élevés.
The frequency and morbidity of the disabling array of symp-
toms frequently encountered by patients on chronic hemodialy-
sis have led to a needed investigation into methodology de-
signed to improve the procedure. For example, the routine use
of a higher osmolality dialysate in recent studies has been
shown to clearly improve the hemodynamic tolerance to dialy-
sis in both acute and longer term trials [1—6]. Another alteration
which recently has been purported to markedly improve symp-
toms on dialysis has been the substitution of bicarbonate for
acetate as the base constituent in dialysate. This maneuver has
been reported to be associated with fewer hypotensive symp-
toms [71, less hypoxemia early in dialysis [8—13], improvement
in rieurologic performance [14, 15], and better maintenance of
the cardiac output [16].
However, uniform agreement regarding the advantages of
bicarbonate dialysate over acetate dialysate does not exist.
Wehle et a! [17] noted no added benefit of bicarbonate over
acetate, particularly if dialysate sodium was increased to 145
mEq/liter. Similarly, Borges, Fryd, and Kjellstrand [18] failed
to document any improvement in the tolerance to weight loss on
bicarbonate dialysis in the setting of acute renal failure. Fur-
ther, Mansell et a! [19] have recently demonstrated that patients
who developed hyperacetatemia during regular dialysis were
still able to maintain an increase in cardiac output. In view of
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Table 1. Dialysis fluid composition
Acetate Bicarbonate
Sodium, mEqiliter 140 140
Chloride, mEq/liter 111.5 106
Potassium, mEqiliter 2.0 2.0
Bicarbonate, mEqiliter — 35
Acetate, mEqiliter 36 4
Calcium, mEqiliter 3.5 3.5
Magnesium, mEqiliter 1.5 1.5
Dextrose, mgldl 250 250
this on-going controversy regarding the efficacy of bicarbonate
dialysate and the expense of changing dialyzer systems to
bicarbonate, the need for a randomized, double-blind, cross-
over study to determine the actual differences in the two
dialysates has been recognized [20].
Therefore, the present series of studies were performed in ten
dialysis patients (using a double-blind protocol approach) to
further elucidate the longer term response to each dialysate. We
were particularly interested to learn if any additional benefits
could be attributed to bicarbonate dialysate when a dialysate
sodium concentration of 140 mEq/liter was employed. Finally,
to determine the effects of bicarbonate and acetate dialysate on
ventilation and gas exchange, we also performed a series of
acute ventilatory studies in seven patients.
Methods
Ten stable chronic hemodialysis patients with intact native
kidneys volunteered for the study. The protocol was approved
by the Institutional Review Board of the University of Texas
Southwestern Medical School, and informed consent was ob-
tained from each of the patients. The mean age of the patients
was 59.7 8.1 (sEM) years and the mean length of time on
dialysis was 53.8 4.8 months. The etiology of the kidney
failure was Kimmelsteil-Wilson Disease (four patients), poly-
cystic kidney disease (two patients), obstructive nephropathy
(two patients), and hypertensive nephrosclerosis and interstitial
nephritis in one patient each. Four of the patients received
antihypertensive medicine chronically, Two of the patients
received clonidine only, one clonidine and propranolol, and one
hydralazine and minoxidil. The doses of this medicine were not
changed during the study. These ten patients were randomly
selected on the basis of clinical stability and the likelihood that
each could undergo the 12-week protocol without an interven-
ing morbid event. Of these ten subjects, two patients routinely
had bouts of significant hypotension on dialysis ( 50% of
dialyses). Both of these patients were diabetic. Each patient
participated in both dialysate protocols which lasted 6 weeks
each and consisted of 5-hr dialyses three times per week. The
same dialyzer (1.3 m2 Travenol Hollow-Fiber, Travenol Labo-
ratories, Deerfield, Illinois) and delivery system (Travenol
RSP) was utilized for all patients.
The dialysis protocol consisted of a 6-week course (a total of
18 dialyses each) employing acetate-containing dialysate versus
bicarbonate-containing dialysate. The content of the two dialy-
sis fluid solutions is listed in Table I and was verified by
laboratory analysis in each case. Five of the patients began on
the acetate dialysate initially, and at the end of the 6 weeks they
were switched to the bicarbonate dialysate; the other five
Table 2. Weight changes during dialysis study
Interdialytic weight gain Intradialytic weight loss
kgkg
Acetate
2.15 2.18
SE 0.23 0.12
Bicarbonate
2.06 2.10
SE 0.14 0.26
P NS NS
patients began with the bicarbonate dialysate and were later
switched to the acetate dialysate. The patients and dialysis staff
were unaware of the crossover time. The dialysates were
prepared prior to the arrival of the patients and medical staff to
the dialysis unit. To obviate observer bias in reporting and
recording information, the patients, nursing staff, and investiga-
tors collecting the data were unaware of which dialysis treat-
ment protocol the patients were undergoing. Further, the
results regarding the course of each dialysis were collected from
the nursing staff dialysis notes at the conclusion of each
dialysis. These records include a constant monitoring of each
patient's symptoms (for example, nausea, vomiting, and muscle
cramping) and the therapy delivered (intravenous hypertonic
saline, normal saline, or mannitol). In the present studies, the
following objective symptoms and signs were prospectively
designated for inclusion in the data analysis: nausea, vomiting,
muscle cramping, diaphoresis, and hypotension. Hypotension
was prospectively defined as a systolic blood pressure <90 mm
Hg. Therapies for these events were hypertonic saline, normal
saline, or mannitol infusions; the type of therapy administered
depended on the severity of the symptoms and the preference of
the dialysis staff. Because of the totally blinded nature of these
protocols, the dialysis staff occasionally administered therapy
for symptoms not prospectively included in the objective signs
and symptoms. Thus, the number of therapeutic interventions
may exceed the incidence of the prospectively defined signs and
symptoms. Supine and standing blood pressures and heart rates
were recorded before, during, and at the conclusion of each
dialysis. Recumbent blood pressure was routinely recorded
every 30 mm during the procedure; weights were measured pre-
and post-dialysis. Mean arterial blood pressure was calculated
by the formula: diastolic blood pressure plus one third of the
pulse pressure. Dialyzer blood flow and transmembrane hydro-
static pressure were adjusted depending on the patient's clinical
requirement for weight loss; these values were recorded at 30-
mm intervals. Blood flows (233 1.5 mi/mm for bicarbonate vs.
232 3.7 mI/mm for acetate, NS) and transmembrane pressures
(228 14.4 mm Hg for bicarbonate vs. 204 22 mm Hg for
acetate, NS) were comparable in the two protocols. At the
beginning of each dialysis week during the study, blood was
obtained pre- and post-dialysis for routine chemistries (ana-
lyzed by flame photometry and a Technicon Autoanalyzer,
Tarrytown, New York), plasma osmolality (freezing point de-
pression, Advanced Instruments, Inc., New Highland, Massa-
chusetts), complete blood count (Coulter Counter), arterial
blood gases with the patients breathing room air (IL 813 Blood
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Table 3. Comparison of weight, mean blood pressure (MBP), and heart rate (HR) changes during acetate and bicarbonate protocols
Pre-dialysis Post-dialysis
Supine Upright Supine Supine Upright Supine
Weight MBP MBP HR Weight MBP MBP HR
kg mm Hg mm Hg min kg mm Hg mm Hg min
Acetate
69.97 99.1 99.5 79 68.13 94.5 90 81.2
SE 4.3 4.1 7.3 3.0 4.3 3.4 6.0 2.6
Bicarbonate
70.59 96.9 99.4 79 68.71 93.9 90.6 80.5
SE 3.9 3.4 6.3 3.8 4.2 2.8 5.6 2.6
P value NS NS NS NS NS NS NS NS
Table 4. Pre- and post-dialysis chemistriesa
Pre
Sodium
Post
Potassium Chloride Bicarbonate
Pre Post Pre Post Pre Post
Acetate
140 139 4.94 3.96 101 101 15.1 19.9
SE 0.6 0.5 0.09 0.08 0.4 0.4 0.82 0.60
Bicarbonate
140 139 5.0 4.0 100 98 19.1 24.7
SE 0.8 0.6 0.09 0.06 0.6 0.6 0.85 0.52
P value NS NS NS NS NS NS <0.001 <0.001
a All values are in mEq/liter.
Gas Analyzer, Instrumentation Laboratories, Lexington, Mas-
sachusetts). During the course of each dialysis protocol, begin-
ning of the week samples for arterial blood gases were obtained
pre-dialysis, at I hr, and post-dialysis. The code identifying the
order of the protocols was not broken until both protocols had
been completed in all of the patients.
In seven of the ten patients, studies of ventilation and gas
exchange were performed. These acute studies were performed
in the final week of the 6-week bicarbonate or acetate protocols.
Timed collections of exhaled gas were collected in a bag
collection system (Douglas, Warren E. Collins, Inc., Braintree,
Massachusetts) pre-dialysis and at 1 hr of dialysis, measured in
a gasometer (Tissot, Warren E. Collins, Inc.), and the volumes
were converted to standard temperature and pressure, dry
(STPD). The oxygen and carbon dioxide contents of exhaled
gas were measured, and from these data total body oxygen
consumption (V02), carbon dioxide excretion (Vco,), and respi-
ratory quotient (RQ) were calculated.
Statistics were performed using Student's paired t to compare
the bicarbonate to acetate results. All data are expressed as the
mean SE. A P value of < 0.05 is considered significant.
Results
Comparison of weights, blood pressures, and heart rate
changes during acetate and bicarbonate protocols (Tables 2
and 3). As shown in Table 2, interdialytic weight gains and
intradialytic weight losses were similar on both dialysates. As
noted in Table 3, these weight changes resulted in comparable
pre- and post-dialysis weights, mean blood pressures, and heart
rates in both protocols. Pre- and post-dialysis supine to upright
mean blood pressures did not decrease significantly in either
protocol. Comparison of the pre- to post-dialysis upright mean
blood pressure revealed a comparable and significant decline in
both protocols (P < 0.05).
Comparison of chemistries during acetate and bicarbonate
protocols (Tables 4 and 5). Pre- and post-dialysis chemistries
were obtained routinely for sodium, potassium, chloride, creati-
nine, and glucose concentrations. The results are shown in
Table 4. As shown in the table, no significant differences in pre-
or post-dialysis sodium, potassium, or chloride concentrations
were noted between the two dialysate mixtures. During the
bicarbonate dialysis protocol, however, pre-dialysis serum bi-
carbonate was higher than with acetate dialysis (19.1 0.85 vs.
15.1 0.82 mEq/liter, P < 0.001). As expected, serum bicar-
bonate concentration increased significantly with both dialy-
sates; however, post-dialysis serum bicarbonate was higher in
the bicarbonate protocol (24.7 0.52 vs. 19.9 0.60 mEq/liter,
P < 0.001).
No significant differences in other pre-dialysis, beginning of
the week chemistries were observed between the two protocols
(Table 5).
Comparison of routine arterial blood gases (ABG's) per-
formed during the course of the study (Table 6). Routine ABG's
were obtained pre-dialysis, at I hr, and post-dialysis at the
beginning of the dialysis week in both protocols. Arterial pH
was greater pre-dialysis during the bicarbonate protocol, in
agreement with the greater bicarbonate concentration pre-
dialysis (Table 4). Slight but significant differences were also
noted in the pre-dialysis Pco2 (higher with the bicarbonate
protocol), and PU2 (lower with bicarbonate). At 1-hr pH and
Pco2 were still different, but PU2 had decreased with acetate
dialysis so that the pre-dialysis difference was no longer pres-
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Table 5. Pre-dialysis beginning of the week chemistries
BUN
Phos-
Calcium phate Albumin
Plasma
osmolality
mOsm/kg
"20
Hemato-
crit
%mg/dI
Acetate
SE
Bicarbonatei
SE
87.9
5.3
85.0
5.4
9.1
0.17
9.4
0.14
5.0
0.5
4.7
0.35
3.81
0.13
3.91
0.17
318.0
1.9
307.0
8.9
22.4
1.1
22.5
1.2
P value NS NS NS NS NS NS
ent. At the completion of dialysis, this pattern persisted, with
pH greater (7.45 0.009 vs. 7.41 0.005, P < 0.001) and Pco2
higher (34.7 0.7 vs. 31.2 0.6 mm Hg, P < 0.005) with
bicarbonate dialysate.
To further examine these differences in ABG's, ventilatory
studies using a bag collecting system (Douglas) were performed
at the conclusion of the 6-week protocol with each dialysate in
seven of the ten patients. These studies were done in addition to
the routine ABG collections and included a simultaneous mea-
surement of ABG's and ventilation. Data were collected pre-
dialysis and at the 1 hr time period of the procedure. The results
of these additional studies are shown in Table 7.
Minute ventilation and carbon dioxide excretion declined at I
hr in both dialysis protocols; oxygen consumption remained
unchanged. Arterial pH and Pco2 were unchanged with acetate
dialysate but increased at 1 hr with bicarbonate dialysate. A
moderate fall in P02 occurred in both dialysis procedures; P02
values were comparable at 1 hr in both protocols.
Comparison of symptoms and signs and therapeutic interven-
tions (Fig. 1). As shown in Figure 1, the frequency of pro spec-
tively defined objective signs and symptoms (hypotension,
nausea, vomiting, cramps, or diaphoresis) during dialysis was
comparable in acetate and bicarbonate dialyses (2.5 0.5 vs.
2.0 0.65 per patient!6 weeks, NS). However, the number of
symptoms and signs which were assessed by the dialysis staff to
require therapy was significantly less for bicarbonate than
acetate HD (1.5 0.43 vs. 3.1 0.6 per patient/6 weeks, P <
0.02).
Discussion
The advisability of changing to the routine use of bicarbonate
dialysate has recently provoked a great deal of interest and
debate because of the central importance of avoiding adverse
symptoms during dialysis. The stability of plasma osmolality
during dialysis has been shown previously to markedly improve
hemodynamic tolerance to weight loss on dialysis [1—6]. In part
this hemodynamic stability afforded by a stable plasma osmolal-
ity is secondary to improved preservation of the plasma volume
during volume reduction on dialysis [3]. At present, however,
the ability of bicarbonate dialysate to independently further
improve hemodynamic and symptomatic tolerance to hemodial-
ysis when a higher osmolality dialysate is used is unresolved.
Accordingly, the present series of studies were designed to
address this question, employing a double-blind crossover
protocol. In addition, the present experiments also included
studies which probe the ventilatory changes associated with
both bicarbonate and acetate dialysate.
The amount of weight loss achieved on dialysis was compara-
ble in the two protocols; interdialytic weight gains were also
quite similar with both dialysates. Comparable hemodynamic
results were obtained during acetate and bicarbonate dialyses
(Table 3). Most importantly, post-dialysis mean supine and
upright blood pressures were nearly identical in both protocols.
The stability of orthostatic mean blood pressure following a
weight loss of this magnitude agrees with prior results obtained
when plasma osmolality is maintained stable during the dialysis
[1, 4]. Although the use of bicarbonate dialysate did not
significantly reduce the number of adverse symptoms and signs
encountered during the course of the study, the number of
therapeutic interventions delivered over the 6-week protocol
was reduced on the bicarbonate protocol (Fig. I). In part, this
reduction is because the adverse symptoms and signs encoun-
tered by the dialysis staff over the periods of observation were
perceived as less severe and were treated less frequently. In the
case of the acetate protocol, since the guidelines for therapy
were not rigidly controlled, but the reported signs and symp-
toms were, a greater number of interventions were recorded
than symptoms encountered (Fig. I). From the standpoint of
hemodynamic stability and number of symptomatic episodes,
this direct comparison of bicarbonate did not reveal detectable
differences. From the viewpoint of the number of therapeutic
interventions administered, however, a modest but significant
improvement with bicarbonate dialysate was observed.
A second area of potential benefit observed with bicarbonate
dialysate was found in the pre-dialysis, beginning the week
chemistries and ABG's which were obtained during the course
of the 6-week trial. Pre-dialysis serum bicarbonate concentra-
tion and arterial pH were both significantly greater while the
patients were being dialyzed on the bicarbonate protocol. It is
of particular interest that the slightly higher post-dialysis pH
and serum bicarbonate achieved with bicarbonate dialysate was
sustained during the interdialytic interval. This higher pH and
serum bicarbonate may be of benefit in retarding the develop-
ment and reducing the severity of renal osteodystrophy [21], a
complicating feature of long-term hemodialysis with cumulative
morbid effects. However, whether these improvements in pH
and bicarbonate are of sufficient magnitude to alter the course
of osteodystrophy is not known. Further, whether these
changes would be sustained over a period of years is also
unknown.
The acute ventilatory studies performed in seven of the
patients extend the ABG results collected over the entire 6-
week course of both protocols. The results of the expired gas
collections at 1 hr of the procedure demonstrate that during
both acetate and bicarbonate dialysis, carbon dioxide diffuses
into the dialysate resulting in acute hypoventilation (shown by
the decrease in YE) in both procedures. During acetate dialysis
isocapnea is maintained, but during bicarbonate dialysis bicar-
bonate diffusion from dialysate induces a respiratory compensa-
tion for the metabolic alkalosis, producing a greater degree of
hypoventilation (16.5 4% for bicarbonate vs. 9.5 4% for
acetate, P <0.05) and therefore a greater increment in arterial
Pco2.
The P02 results obtained in the acute ventilatory studies and
the 6-week studies differ slightly and deserve comment. In the
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Table 6. Beginning of the week arterial blood gases
Pre-dialysis ABG's 1-hr ABG's Post-dialysis ABG's
pH Pco2 PU2 pH Pco2 P02 pH Pco2 P02
units torr torr units torT torr Units torr torr
Acetate
7.35 31.6 101 7.36 32.2 87.7 7.41 31.2 90.4
sE 0.011 0.71 3.4 0.004 0.52 2.9 0.009 0.6 3.7
Bicarbonate
7.40 33.4 91 7.40 34.8 90.1 7.45 34.7 85.7
SE 0.012 0.39 3.4 0.008 0.27 3.7 0.009 0.7 4.1
P value 0.01 0.05 0.02 0.01 0.001 NS 0.001 0.005 NS
Table 7. Simultaneous ABG and ventilatory studies pre-dialysis and at 1 hr
Pco2
Pre 1 hr Pre 1 hr Pre 1 hr Pre 1 hr
liters/mm mi/mm mi/mm tOrr
P02
Pre
torr
1 hr Pre
pH
Units
1 hr
Acetate
10.8 9.6 222 175 260 244 32 32 92 85 7.39 7.37
SE 1.2 0.8 26 15 26 22 2 2 6 6 0.02 0.01
P 0.05 0.01 NS NS 0.05 NS
Bicarbonate
12.7 10.2 245 198 280 254 33 37a 98 87 7.41 7.42
SE 2.7 1.9 23 18 21 25 3 3 6 6 0.02 0.02
P 0.05 0.02 NS 0.05 0.05 0.05
Abbreviations: VU, minute ventilation; Vc02, carbon dioxide excretion; V0,, oxygen consumption.
P < 0.05, bicarbonate vs. acetate.
Fig. 1. Symptoms and therapeutic interventions during dialysis proto-
cols. The left panel represents the symptoms and signs during dialysis
( + SE) and the right panel therapeutic interventions (5 + SE). Symbols
are: , acetate dialysate; , bicarbonate dialysate.
acute ventilatory studies, the baseline P02 values were compa-
rable with both dialysates and a modest but significant decline
in P02 occurred during the first hour. In contrast, in the ABG
data collected from all ten patients over the course of the 6-
week protocol, the mean baseline P02 was significantly higher
during the acetate protocol than during the bicarbonate trial.
However, a sharp decline in P02 during the first hour of dialysis
was noted with acetate dialysate, and this decline resulted in
comparable values for acetate and bicarbonate at 1 hr. Both the
acute ventilatory studies and the longer term results agree in
that comparable P02 values are present with both dialysates at
1 hr. The acute ventilatory results further demonstrate a clear
decline in Vco, and V1 with both dialysates and agree with the
recent results of Eiser et al [22] using baths of similar composi-
tion. These authors also reported an increase in V0, during
acetate dialysis; however, no increase in V0. was observed with
the dialysates in this study. The reasons for this difference are
unclear at present.
In summary, the results of this prospective direct comparison
of acetate and bicarbonate dialysates in the setting of a higher
dialysate sodium concentration (140 mEq/liter) show compara-
ble hemodynamic results (as assessed by orthostatic tolerance
to weight loss and heart rate changes). In addition, the inci-
dence of hypotension and several other adverse symptoms
during dialysis was also similar, although treatment interven-
tions were reduced significantly during the bicarbonate proto-
col. Patients also had higher serum bicarbonate and pH values
pre- and post-dialysis while on bicarbonate dialysate, but a
slightly greater degree of hypoventilation also occurred during
the bicarbonate protocol at 1 hr. In the aggregate, bicarbonate
dialysate offers only moderate improvement over acetate dialy-
sate when a dialysate sodium of at least 140 mEq/liter is used.
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